Comparison

CD45RA

Manufacturer GENWAY
Category
Type Antibody
Specific against other
Clone Bu78
Applications FC
Amount 0.025 mg
Item no. 20-783-310546
eClass 6.1 32160702
eClass 9.0 32160702
Available
Genway ID:
GWB-21C52F
Specificity:
CD45RA
Specificity:
CD45RA
Clone:
Bu78
Preparation:
Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Buffer Solution:
Phosphate buffered saline pH7. 4
Preservative Stabilisers:
0. 09%Sodium Azide (NaN3) Suggested
Flow Cytometry:
Use 10ul of the suggested working dilution to label 1x106 cells in 100ul. Suggested
Dilution:
Flow Cytometry - 1/25 - 1/100
Function:
Required for T-cell activation through the antigen receptor. The first PTPase domain has enzymatic activity while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation recruits an dephosphorylates SKAP1 and FYN.
Catalytic Activity:
Protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
Subunit:
Binds GANAB and PRKCSH (By similarity). Interacts with SKAP1.
Subcellular Location:
Membrane; Single-pass type I membrane protein.
Domain:
The first PTPase domain interacts with SKAP1.
Ptm:
Heavily N- and O-glycosylated.
Disease:
Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+)SCID) [MIM:608971]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity leukopenia and low or absent antibody levels. Patients with SCID present in infancy with recurrent persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Disease:
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.
Similarity:
Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Similarity:
Contains 2 fibronectin type-III domains.
Similarity:
Contains 2 tyrosine-protein phosphatase domains.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.025 mg
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close